Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-26

Clinical Trial Update: Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial comparing low molecular weight heparin versus direct oral anticoagulants after bariatric surgery to manage deep vein thrombosis risk. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Direct Oral Anticoagulant
  • Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Cairo University | Conditions: Deep Venous Thrombosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING